Skip to main content
. 2021 Dec 12;11(12):e049541. doi: 10.1136/bmjopen-2021-049541

Table 1.

Baseline characteristics in knee and hip patients attending GLA:D

Knee Hip
(n: 12 162) (n: 4093)
Age (years), mean (SD) 64.1 (9.8) 65.7 (9.4)
Gender (female), % (n) 73.1 (8887) 73.6 (3014)
BMI (kg/m2), mean (SD) 28.6 (5.3) 26.9 (4.6)
Marital status, % (n)
Married or living with others 72.4 (8803) 70.7 (1079)
Single 27.6 (3359) 29.3 (1200)
Ethnic background, % (n)
Danish 96.2 (11 701) 96.8 (3961)
Other western 2.5 (299) 2.6 (106)
Not western 1.3 (160) 0.6 (25)
Educational level, % (n)
Primary 18.7 (2277) 19.7 (1493)
Secondary 3.0 (367) 2.7 (112)
Vocational 39.1 (4761) 36.2 (1481)
Short-term 4.6 (558) 4.5 (185)
Bachelor 26.2 (3186) 28.0 (1145)
Long-term 7.2 (873) 8.0 (329)
Unknown 1.2 (140) 0.9 (35)
Social status, % (n)
Employed 43.3 (5264) 36.5 (1493)
Unemployed 2.1 (256) 1.5 (61)
Sick pay (public funded) 0.7 (86) 0.4 (15)
Disability pension 3.7 (444) 3.7 (152)
Early retirement 6.3 (766) 7.3 (297)
Age pension 42.8 (5209) 49.5 (2028)
Other 1.1 (137) 1.1 (47)
Administrative region, % (n)
Capital Region 27.7 (3367) 27.6 (1131)
Region Zealand 13.0 (1578) 13.1 (535)
Region of Southern Denmark 21.8 (2654) 25.2 (1030)
Central Denmark Region 25.4 (3085) 24.9 (1021)
North Denmark Region 12.2 (1478) 9.2 (376)
Number of comorbidities*, % (n)
0 38.2 (4367) 39.7 (1533)
1 35.7 (4076) 35.1 (1358)
2 17.3 (1979) 16.8 (649)
3 or more 8.8 (1.006) 8.4 (326)
Symptom duration (months), median (IQR) 24 (7–60) 24 (8–48)
Pain intensity (VAS 0–100, best to worst), mean (SD) 48.6 (22.0) 47.6 (21.7)
Bilateral symptoms, % (n) 46.3 (5614) 26.1 (1064)
Walk speed† (m/s), mean (SD) 1.49 (0.33) 1.49 (0.34)
Previous surgery in worst joint‡, % (n) 30.7 (3725) 4.0 (161)
Use of pain medication§ (yes), % (n)
Overall 61.3 (7431) 64.2 (2629)
Paracetamol 49.9 (6073) 53.3 (2184)
NSAIDs 35.6 (4325) 34.6 (1419)
Opioids 7.1 (868) 9.0 (367)
KOOS/HOOS QOL¶ (0–100, best to worst), mean (SD) 45.2 (14.7) 47.4 (15.1)

Missing values: BMI n: 5 (knee), n: 7 (hip); number of comorbidities n: 711 (knee), n: 215 (hip); symptom duration (mainly missing due to technical problems): n: 3.157 (knee), n: 1096 (hip); pain intensity: n: 23 (knee), n: 9 (hip); bilateral symptoms: n: 32 (knee), n: 20 (hip); walk speed: n: 610 (knee), n: 221 (hip); KOOS/HOOS QOL: n: 36 (knee), n: 21 (hip).

*Number of comorbidities calculated from self-report of the following conditions: hypertension, cardiovascular diseases, lung diseases, diabetes, stomach diseases, liver or kidney diseases, blood diseases, cancer, depression, rheumatoid arthritis, neurological disorders, other medical diseases.

†Walking speed was assessed with the 40 m fast-paces walk test under instruction of the GLA:D therapist.

‡Self-reported previous surgery in worst joint.

§Self-reported use of pain medication during last 3 months.

¶KOOS or HOOS Quality of Life sub-scale score.

BMI, body mass index; GLA:D, Good Life with osteoArthritis in Denmark; HOOS, Hip disability and Osteoarthritis Outcome Score; KOOS, Knee injury and Osteoarthritis Outcome Score; NSAIDs, Non-Steoridal Anti-Inflammatory Drugs; QOL, quality of life; VAS, visual analogue scale.